Great-West Lifeco Inc. (GWLIF)
| Market Cap | 50.03B +40.6% |
| Revenue (ttm) | 25.79B +3.2% |
| Net Income | 3.07B +12.6% |
| EPS | 3.33 +12.8% |
| Shares Out | n/a |
| PE Ratio | 16.27 |
| Forward PE | 13.49 |
| Dividend | 1.81 (3.31%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 688 |
| Average Volume | 23,223 |
| Open | 55.83 |
| Previous Close | 55.77 |
| Day's Range | 54.65 - 55.83 |
| 52-Week Range | 32.87 - 55.83 |
| Beta | 0.69 |
| RSI | 69.02 |
| Earnings Date | May 6, 2026 |
About Great-West Lifeco
Great-West Lifeco Inc. engages in the life and health insurance, retirement savings, wealth and asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers life, accidental death and dismemberment, critical illness, disability, health and dental protection, and creditor insurance products; and retirement savings, income and annuity products, and other specialty products to individuals, families, businesses, and organizations. It also provides individual product solutions and employer-sponsored retir... [Read more]
Financial Performance
In 2025, Great-West Lifeco's revenue was 35.45 billion, an increase of 2.04% compared to the previous year's 34.74 billion. Earnings were 3.96 billion, an increase of 0.51%.
Financial numbers in CAD Financial StatementsNews
Great-West Lifeco price target raised to C$83 from C$78 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$83 from C$78 and keeps an Outperform rating on the shares.
Great-West Lifeco price target raised to C$76 from C$70 at BMO Capital
BMO Capital raised the firm’s price target on Great-West Lifeco (GWLIF) to C$76 from C$70 and keeps a Market Perform rating on the shares.
Great-West Lifeco price target raised to C$81 from C$75 at CIBC
CIBC raised the firm’s price target on Great-West Lifeco (GWLIF) to C$81 from C$75 and keeps an Outperformer rating on the shares.
Great-West Lifeco price target raised to C$80 from C$73 at TD Securities
TD Securities raised the firm’s price target on Great-West Lifeco (GWLIF) to C$80 from C$73 and keeps a Buy rating on the shares.
Great-West Lifeco Earnings Call Transcript: Q1 2026
Double-digit earnings growth and record base ROE marked a strong Q1 2026, with all segments contributing and robust capital generation supporting share buybacks and future growth. Empower and CRS led performance, while disciplined risk and capital management underpin a positive outlook.
Great-West Lifeco price target raised to C$73 from C$70 at Barclays
Barclays raised the firm’s price target on Great-West Lifeco (GWLIF) to C$73 from C$70 and keeps an Equal Weight rating on the shares.
Great-West Lifeco Inc. Profit Climbs In Q1
(RTTNews) - Great-West Lifeco Inc. (GWO.TO) revealed earnings for its first quarter that Increases, from the same period last year
Great-West Lifeco price target raised to C$78 from C$71 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$78 from C$71 and keeps an Outperform rating on the shares.
PTSB analysis – Bawag shares hit all-time high as market number-crunchers see Irish taxpayer as big loser in bank sale
In 2013 the then Irish government gave away Irish Life for a bargain-basement price and handed the buyer, Canada’s Great-West Lifeco, the chance to reap billions in dividends
Great-West Lifeco price target raised to C$64 from C$60 at RBC Capital
RBC Capital raised the firm’s price target on Great-West Lifeco (GWLIF) to C$64 from C$60 and keeps a Sector Perform rating on the shares.
Great-West Lifeco price target lowered to C$66 from C$68 at BMO Capital
BMO Capital analyst Tom MacKinnon lowered the firm’s price target on Great-West Lifeco (GWLIF) to C$66 from C$68 and keeps a Market Perform rating on the shares. Published first on
Great-West Lifeco price target raised to C$71 from C$70 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$71 from C$70 and keeps an Outperform rating on the shares.
Great-West Lifeco upgraded to Buy from Hold at Jefferies
Jefferies analyst John Aiken upgraded Great-West Lifeco (GWLIF) to Buy from Hold with a price target of C$70, up from C$67. Coming out of the third quarter, there were questions
Great-West Lifeco Earnings Call Transcript: Q4 2025
Record base earnings and double-digit EPS growth were driven by strong performance across all segments, robust capital generation, and disciplined capital deployment. Empower and wealth businesses led growth, while capital was returned to shareholders through buybacks and a dividend increase.
Great-West Lifeco price target raised to C$70 from C$68 at Scotiabank
Scotiabank raised the firm’s price target on Great-West Lifeco (GWLIF) to C$70 from C$68 and keeps an Outperform rating on the shares.
Great-West Lifeco price target raised to C$73 from C$67 at CIBC
CIBC raised the firm’s price target on Great-West Lifeco (GWLIF) to C$73 from C$67 and keeps an Outperformer rating on the shares.
Great-West Lifeco price target raised to C$70 from C$59 at Barclays
Barclays raised the firm’s price target on Great-West Lifeco (GWLIF) to C$70 from C$59 and keeps an Equal Weight rating on the shares. The firm is “cautiously optimistic” on life
Great-West Lifeco Earnings Call Transcript: Q3 2025
Record Q3 base earnings grew 15% year-over-year, with all segments contributing to strong results. Capital and risk solutions saw 20% earnings growth, and Empower Wealth surpassed $100 billion in assets. Share buybacks increased, and robust cash flow supports ongoing growth.
Great-West Lifeco announces offering of Series Z Preferred Shares
Not for distribution to U.S. news wire services or dissemination in the United States. THE BASE SHELF PROSPECTUS IS ACCESSIBLE, AND THE SHELF PROSPECTUS SUPPLEMENT FOR THE PUBLIC OFFERING AND ANY AMEN...
Great-West Lifeco Transcript: Barclays 23rd Annual Global Financial Services Conference
Focused on expanding capital-light businesses, raising earnings and ROE targets, and deepening U.S. wealth market penetration. Strong organic growth, disciplined M&A, and tech-driven efficiency initiatives underpin strategy, with leading positions in core markets and ongoing industry consolidation expected.
Great-West Lifeco Transcript: 2025 Scotiabank Financials Summit
Leadership transition brings continuity, with a focus on organic growth, digital transformation, and capital-light strategy. Empower drives U.S. growth, while Europe and Canada remain stable with targeted expansion. Strong capital position supports buybacks and future M&A.
Great-West Lifeco Transcript: Fireside Chat
The session highlighted a consistent strategic direction focused on capital-light growth, disciplined M&A, and technology-driven efficiency. Ambitious ROE and efficiency targets are underpinned by strong market positions, especially in the U.S. and Europe, and ongoing investments in AI and digital platforms.
Empower Reports Second Quarter 2025 Base Earnings of $247 Million, Up 13% Year Over Year
GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--Empower today announced after tax base earnings of $247 million for the second quarter of 2025, a 13% increase from the same period in 2024 excluding the imp...
Great-West Lifeco Earnings Call Transcript: Q2 2025
Record Q2 base earnings and double-digit growth were driven by strong U.S. and wealth performance, disciplined capital allocation, and product innovation. Empower remains a key growth engine, with robust net flows and high retention, while capital strength supports increased buybacks.
Canada Life Reinsurance strengthens focus on structured reinsurance; ceases new business for U.S. traditional mortality risk reinsurance
BLUE BELL, Pa. , June 25, 2025 /PRNewswire/ - Today, Canada Life Reinsurance, a wholly owned subsidiary of Great-West Lifeco Inc. (TSX: GWO) ("Lifeco") announced some changes to its business strategy.